Skip to content
OpenCapital
Get started

Pacific Biosciences of California PACB Enterprise value

Enterprise value at other companies

Illumina logo
IlluminaILMN
$19.8B+46.0%
Revvity logo
RevvityRVTY
$12.88B-13.7%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$519.22M+44.6%
Agilent Technologies logo
Agilent TechnologiesA
$34.39B+5.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$222.48B+0.9%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$2.9B+30.4%

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Calculated from Pacific Biosciences of California’s reported figures.

$398.6Mmarket cap+$59.3Mtotal debt−$57.9Mcash and equivalents=$400.05M

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's enterprise value?
Pacific Biosciences of California (PACB) reported enterprise value of $400.05M in Q1 2026.
How has Pacific Biosciences of California's enterprise value changed year-over-year?
Pacific Biosciences of California's enterprise value increased by 16.4% year-over-year, from $343.63M to $400.05M.
What is the long-term trend for Pacific Biosciences of California's enterprise value?
Over 5 years (2020 to 2025), Pacific Biosciences of California's enterprise value has grown at a -35.5% compound annual growth rate (CAGR), from $5B to $556.35M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.